141 related articles for article (PubMed ID: 25143180)
1. Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature.
Deutschbein T; Fassnacht M; Weismann D; Reincke M; Mann K; Petersenn S
Clin Endocrinol (Oxf); 2015 Jan; 82(1):84-90. PubMed ID: 25143180
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
Deutschbein T; Matuszczyk A; Moeller LC; Unger N; Yuece A; Lahner H; Mann K; Petersenn S
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):540-3. PubMed ID: 21667440
[TBL] [Abstract][Full Text] [Related]
3. Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.
Asai S; Katabami T; Tsuiki M; Tanaka Y; Naruse M
Horm Cancer; 2017 Apr; 8(2):108-118. PubMed ID: 28108930
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
Huang H; Abraham J; Hung E; Averbuch S; Merino M; Steinberg SM; Pacak K; Fojo T
Cancer; 2008 Oct; 113(8):2020-8. PubMed ID: 18780317
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.
Wang Y; Liu B; Xu D; Zhao H; Zhu Y; Xu J; Tao R
Neurol India; 2013; 61(3):260-4. PubMed ID: 23860145
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma.
Tanabe A; Naruse M; Nomura K; Tsuiki M; Tsumagari A; Ichihara A
Horm Cancer; 2013 Apr; 4(2):103-10. PubMed ID: 23361939
[TBL] [Abstract][Full Text] [Related]
7. [A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine].
Naoi Y; Tamaki Y; Ooka M; Tsukamoto F; Miyoshi Y; Tanji Y; Taguchi T; Noguchi S
Gan To Kagaku Ryoho; 2003 Jan; 30(1):145-9. PubMed ID: 12557721
[TBL] [Abstract][Full Text] [Related]
8. Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
Wu LT; Dicpinigaitis P; Bruckner H; Manger W; Averbuch S
Med Pediatr Oncol; 1994; 22(6):389-92. PubMed ID: 8152400
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy.
Nomura K; Kimura H; Shimizu S; Kodama H; Okamoto T; Obara T; Takano K
J Clin Endocrinol Metab; 2009 Aug; 94(8):2850-6. PubMed ID: 19470630
[TBL] [Abstract][Full Text] [Related]
10. [A case of malignant pheochromocytoma treated with a combination of cyclophosphamide, vincristine, and dacarbazine (CVD). A review of the Japanese literature of malignant pheochromocytoma treated with a combination of CVD].
Mizuno O
Nihon Naibunpi Gakkai Zasshi; 1994 Nov; 70(9):1039-46. PubMed ID: 7851622
[TBL] [Abstract][Full Text] [Related]
11. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine.
Averbuch SD; Steakley CS; Young RC; Gelmann EP; Goldstein DS; Stull R; Keiser HR
Ann Intern Med; 1988 Aug; 109(4):267-73. PubMed ID: 3395037
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of malignant pheochromocytoma. Invitation to participate in a randomized multicenter study].
Mundschenk J; Kopf D; Lehnert H
Dtsch Med Wochenschr; 1998 Jan; 123(1-2):32-3. PubMed ID: 9465855
[No Abstract] [Full Text] [Related]
13. Two cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine and dacarbazine in a combined chemotherapy.
Noshiro T; Honma H; Shimizu K; Kusakari T; Watanabe T; Akama H; Shibukawa S; Miura W; Abe K; Miura Y
Endocr J; 1996 Jun; 43(3):279-84. PubMed ID: 8886621
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
Niemeijer ND; Alblas G; van Hulsteijn LT; Dekkers OM; Corssmit EP
Clin Endocrinol (Oxf); 2014 Nov; 81(5):642-51. PubMed ID: 25041164
[TBL] [Abstract][Full Text] [Related]
15. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
16. Clinical review: Current treatment of malignant pheochromocytoma.
Scholz T; Eisenhofer G; Pacak K; Dralle H; Lehnert H
J Clin Endocrinol Metab; 2007 Apr; 92(4):1217-25. PubMed ID: 17284633
[TBL] [Abstract][Full Text] [Related]
17. [Malignant pheochromocytoma with remarkable response to CVD chemotherapy--a case report].
Suzuki M; Mikata N; Imao S; Ishiwata S; Nagano T
Gan To Kagaku Ryoho; 2000 Jun; 27(6):921-4. PubMed ID: 10897222
[TBL] [Abstract][Full Text] [Related]
18. [A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and CVD regimen].
Ukimura O; Kojima M; Hosoi S; Itoh H; Watanabe H; Minamikawa T
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):811-4. PubMed ID: 8022145
[TBL] [Abstract][Full Text] [Related]
19. Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
Robert C; Dummer R; Gutzmer R; Lorigan P; Kim KB; Nyakas M; Arance A; Liszkay G; Schadendorf D; Cantarini M; Spencer S; Middleton MR
Lancet Oncol; 2013 Jul; 14(8):733-40. PubMed ID: 23735514
[TBL] [Abstract][Full Text] [Related]
20. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
